This site is intended for healthcare professionals
Industry news

Allergan buys Oculeve for $125 million

Read time: 1 mins
Last updated:7th Jul 2015
Published:7th Jul 2015
Source: Pharmawand
Allergan has paid $125 million for venture-backed Oculeve, a med-tech startup with a nerve-stimulating implant called OD-01 which is an innovative treatment for dry eye disease. Oculeve was founded by Stanford University's Michael Ackermann in 2011.

Learning Zones

The Learning Zones are an educational resource for healthcare professionals that provide medical information on the epidemiology, pathophysiology and burden of disease, as well as diagnostic techniques and treatment regimens.